# A Study of KK2269 in Adult Participants With Solid Tumors

> **NCT06266299** · PHASE1 · RECRUITING · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 101 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Metastatic Solid Tumor
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Esophageal Adenocarcinoma
- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** KK2269
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT06266299
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-18
- **Primary completion:** 2029-03
- **Final completion:** 2029-03
- **Target enrollment:** 101 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06266299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06266299, "A Study of KK2269 in Adult Participants With Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06266299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*